RANIBIZUMAB ( DrugBank: Ranibizumab )


4 diseases
IDDisease name (Link within this page)Number of trials
34Neurofibromatosis1
166Pseudoxanthoma elasticum4
227Osler disease1
301Macular dystrophy1

34. Neurofibromatosis


Clinical trials : 133Drugs : 186 - (DrugBank : 67) / Drug target genes : 79 - Drug target pathways : 190 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

166. Pseudoxanthoma elasticum


Clinical trials : 16Drugs : 27 - (DrugBank : 5) / Drug target genes : 5 - Drug target pathways : 28 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

227. Osler disease


Clinical trials : 56Drugs : 72 - (DrugBank : 21) / Drug target genes : 23 - Drug target pathways : 136 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

301. Macular dystrophy


Clinical trials : 46Drugs : 42 - (DrugBank : 11) / Drug target genes : 9 - Drug target pathways : 67 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries